Barriers to the care of HIV-infected children in rural Zambia: A cross-sectional analysis

BMC Infectious Diseases

Volumn 9, Issue , 2009, Pages 169-

  Van Dijk, Janneke H ^a   Sutcliffe, Catherine G ^b   Munsanje, Bornface ^a   Hamangaba, Francis ^a   Thuma, Philip E ^a   Moss, William J ^b  

^a Macha Hospital   (Zambia)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EFAVIRENZ; LAMIVUDINE; LAMIVUDINE PLUS NEVIRAPINE PLUS ZIDOVUDINE; NEVIRAPINE; STAVUDINE; ZIDOVUDINE;

ARTICLE; CAREGIVER; CD4 LYMPHOCYTE COUNT; CHILD; CHILD CARE; CROSS-SECTIONAL STUDY; FEMALE; FOLLOW UP; HEALTH CARE ACCESS; HEALTH CARE DELIVERY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MONEY; OUTPATIENT DEPARTMENT; PRESCHOOL CHILD; RURAL AREA; TRAVEL; TREATMENT DURATION; TREATMENT RESPONSE; UNDERWEIGHT; WEIGHT GAIN; ZAMBIA;

EID: 70449635245     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-9-169     Document Type: Article

References (31)

1. UNAIDS 2008 Report on the global AIDS epidemic. 2008, Geneva, Switzerland: Joint United Nations Programme on HIV/AIDS.
2. The 3 by 5 Initiative. , http://www.who.int/3by5/en/
3. WHO Towards Universal Access: Scaling up priority HIV/AIDS interventions in the health sector: Progress Report 2008. 2008, Geneva, Switzerland: World Health Organization.
4. Harries AD, Nyangulu DS, Hargreaves NJ, Kaluwa O, Salaniponi FM. Preventing antiretroviral anarchy in sub-Saharan Africa. Lancet 2001, 358:410-414. 10.1016/S0140-6736(01)05551-9, 11502341.
5. Stevens W, Kaye S, Corrah T. Antiretroviral therapy in Africa. BMJ 2004, 328:280-282. 10.1136/bmj.328.7434.280, 324462, 14751902.
6. Sutcliffe CG, van Dijk JH, Bolton C, Persaud D, Moss WJ. Effectiveness of antiretroviral therapy among HIV-infected children in sub-Saharan Africa. Lancet Infect Dis 2008, 8:477-489. 10.1016/S1473-3099(08)70180-4, 18652994.
7. Scott VE, Chopra M, Conrad L, Ntuli A. How equitable is the scaling up of HIV service provision in South Africa?. S Afr Med J 2005, 95:109-113.
8. Ojikutu B. Introduction: the realities of antiretroviral therapy rollout: overcoming challenges to successful programmatic implementation. J Infect Dis 2007, 196(Suppl 3):S445-448. 10.1086/521123, 18181692.
9. Egger M, Boulle A, Schechter M, Miotti P. Antiretroviral therapy in resource-poor settings: scaling up inequalities?. Int J Epidemiol 2005, 34:509-512. 10.1093/ije/dyi110, 15941732.
10. WHO Taking Stock: Health worker shortages and the response to AIDS. 2006, Geneva, Switzerland: World Health Organization.
11. Landman KZ, Thielman NM, Mgonja A, Shao HJ, Itemba DK, Ndosi EM, Tribble AC, Shao JF, Bartlett JA, Crump JA. Antiretroviral treatment literacy among HIV voluntary counseling and testing clients in Moshi, Tanzania, 2003 to 2005. J Int Assoc Physicians AIDS Care (Chic Ill) 2007, 6:24-26. 10.1177/1545109706298479, 17329501.
12. Rosen S, Ketlhapile M, Sanne I, Desilva MB. Characteristics of Patients Accessing Care and Treatment for HIV/AIDS at Public and Nongovernmental Sites in South Africa. J Int Assoc Physicians AIDS Care (Chic Ill) 2008, 7:200-207. 10.1177/1545109708320684, 18626120.
13. Mshana GH, Wamoyi J, Busza J, Zaba B, Changalucha J, Kaluvya S, Urassa M. Barriers to accessing antiretroviral therapy in Kisesa, Tanzania: a qualitative study of early rural referrals to the national program. AIDS Patient Care STDS 2006, 20:649-657. 10.1089/apc.2006.20.649, 16987051.
14. Wools-Kaloustian K, Kimaiyo S. Extending HIV care in resource-limited settings. Curr HIV/AIDS Rep 2006, 3:182-186. 10.1007/s11904-006-0014-1, 17032578.
15. Fredlund VG, Nash J. How far should they walk? Increasing antiretroviral therapy access in a rural community in northern KwaZulu-Natal, South Africa. J Infect Dis 2007, 196(Suppl 3):S469-473. 10.1086/521115, 18181696.
16. Bedelu M, Ford N, Hilderbrand K, Reuter H. Implementing antiretroviral therapy in rural communities: the Lusikisiki model of decentralized HIV/AIDS care. J Infect Dis 2007, 196(Suppl 3):S464-468. 10.1086/521114, 18181695.
17. Weidle PJ, Wamai N, Solberg P, Liechty C, Sendagala S, Were W, Mermin J, Buchacz K, Behumbiize P, Ransom RL, Bunnell R. Adherence to antiretroviral therapy in a home-based AIDS care programme in rural Uganda. Lancet 2006, 368:1587-1594. 10.1016/S0140-6736(06)69118-6, 17084759.
18. Barth RE, Meer JT, Hoepelman AI, Schrooders PA, Vijver DA, Geelen SP, Tempelman HA. Effectiveness of highly active antiretroviral therapy administered by general practitioners in rural South Africa. Eur J Clin Microbiol Infect Dis 2008, 27:977-984. 10.1007/s10096-008-0534-2, 18629557.
19. Carlucci JG, Kamanga A, Sheneberger R, Shepherd BE, Jenkins CA, Spurrier J, Vermund SH. Predictors of adherence to antiretroviral therapy in rural Zambia. J Acquir Immune Defic Syndr 2008, 47:615-622. 10.1097/QAI.0b013e318165dc25, 2743102, 18209678.
20. Ferradini L, Jeannin A, Pinoges L, Izopet J, Odhiambo D, Mankhambo L, Karungi G, Szumilin E, Balandine S, Fedida G. Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment. Lancet 2006, 367:1335-1342. 10.1016/S0140-6736(06)68580-2, 16631912.
21. WHO Antiretroviral therapy of HIV infection in infants and children: Towards universal access. Recommendations for a public health approach. 2006, Geneva, Switzerland: World Health Organization.
22. The WHO child growth standards. , http://www.who.int/childgrowth/en/index.html
23. Lusaka ZCSO Zambia Demographic and Health Survey 2001-2002. 2003, Calverton, Maryland, USA: ORC and Macro International, Inc..
24. Bolton-Moore C, Mubiana-Mbewe M, Cantrell RA, Chintu N, Stringer EM, Chi BH, Sinkala M, Kankasa C, Wilson CM, Wilfert CM. Clinical outcomes and CD4 cell response in children receiving antiretroviral therapy at primary health care facilities in Zambia. Jama 2007, 298:1888-1899. 10.1001/jama.298.16.1888, 17954540.
25. Sutcliffe CG, Scott S, Mugala N, Ndhlovu Z, Monze M, Quinn TC, Cousens S, Griffin DE, Moss WJ. Survival from 9 months of age among HIV-infected and uninfected Zambian children prior to the availability of antiretroviral therapy. Clin Infect Dis 2008, 47:837-844. 10.1086/591203, 2753245, 18680417.
26. Violari A, Cotton MF, Gibb DM, Babiker AG, Steyn J, Madhi SA, Jean-Philippe P, McIntyre JA. Early antiretroviral therapy and mortality among HIV-infected infants. N Engl J Med 2008, 359:2233-2244. 10.1056/NEJMoa0800971, 19020325.
27. Feucht UD, Kinzer M, Kruger M. Reasons for delay in initiation of antiretroviral therapy in a population of HIV-infected South African children. J Trop Pediatr 2007, 53:398-402. 10.1093/tropej/fmm060, 17965099.
28. Marazzi MC, Germano P, Liotta G, Buonomo E, Guidotti G, Palombi L. Pediatric highly active antiretroviral therapy in Mozambique: an integrated model of care. Minerva Pediatr 2006, 58:483-490.
29. Vreeman RC, Wiehe SE, Ayaya SO, Musick BS, Nyandiko WM. Association of antiretroviral and clinic adherence with orphan status among HIV-infected children in Western Kenya. J Acquir Immune Defic Syndr 2008, 49:163-170. 10.1097/QAI.0b013e318183a996, 18769353.
30. Polisset J, Ametonou F, Arrive E, Aho A, Perez F. Correlates of Adherence to Antiretroviral Therapy in HIV-Infected Children in Lome, Togo, West Africa. AIDS Behav 2009, 13:23-32. 10.1007/s10461-008-9437-6, 18654845.
31. Kabue MM, Kekitiinwa A, Maganda A, Risser JM, Chan W, Kline MW. Growth in HIV-infected children receiving antiretroviral therapy at a pediatric infectious diseases clinic in Uganda. AIDS Patient Care STDS 2008, 22:245-251. 10.1089/apc.2007.0049, 18298315.